Literature DB >> 28756131

Platelet-rich plasma promotes the development of isolated human primordial and primary follicles to the preantral stage.

Laleh Hosseini1, Abolfazl Shirazi2, Mohammad Mehdi Naderi3, Naser Shams-Esfandabadi4, Sara Borjian Boroujeni3, Ali Sarvari3, Samaneh Sadeghnia3, Bahareh Behzadi3, Mohammad Mehdi Akhondi3.   

Abstract

This study aimed to assess the effects of platelet-rich plasma (PRP) on growth and survival of isolated early human follicles in a three-dimensional culture system. After fresh and vitrified-warmed ovarian tissue was digested, isolated early preantral follicles and ovarian cells were separately encapsulated in 1% alginate (w/v). The encapsulated follicles and ovarian cells were cultured together in a medium supplemented with foetal bovine serum (FBS), PRP, PRP + FBS, or human serum albumin (HSA) for 10 days. Growth and survival of the follicles were assessed by measurement of diameter and staining with trypan blue. Follicular integrity was assessed by histological analysis. After culturing, all follicles increased in size, but growth rate was greater in follicles isolated from fresh samples than those from vitrified-warmed ones (P < 0.001). Similarly, follicular viability of fresh samples after culturing was higher than that of vitrified-warmed ones. The growth and survival rates of follicles from both fresh and vitrified groups cultured in PRP supplemented media were significantly higher than those of other groups (growth P < 0.001 and survival P < 0.05, in both groups). In conclusion, media supplementation with PRP can better support viability and growth of isolated human early preantral follicles in vitro.
Copyright © 2017 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3D culture; Human primordial follicle; Ovarian cortical tissue; Platelet-rich plasma; Vitrification

Mesh:

Substances:

Year:  2017        PMID: 28756131     DOI: 10.1016/j.rbmo.2017.04.007

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  23 in total

1.  Platelet-rich plasma therapy and reproductive medicine.

Authors:  Adriana Bos-Mikich; Ricardo de Oliveira; Nilo Frantz
Journal:  J Assist Reprod Genet       Date:  2018-03-21       Impact factor: 3.412

Review 2.  Ovarian response to intraovarian platelet-rich plasma (PRP) administration: hypotheses and potential mechanisms of action.

Authors:  Serin Seckin; Hadi Ramadan; Marco Mouanness; Michelle Kohansieh; Zaher Merhi
Journal:  J Assist Reprod Genet       Date:  2022-02-17       Impact factor: 3.412

3.  Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study.

Authors:  D H Barad; D F Albertini; E Molinari; N Gleicher
Journal:  Hum Reprod Open       Date:  2022-06-28

Review 4.  Platelet-Rich Plasma as an Alternative to Xenogeneic Sera in Cell-Based Therapies: A Need for Standardization.

Authors:  Eduardo Anitua; Mar Zalduendo; Maria Troya; Mohammad H Alkhraisat; Leticia Alejandra Blanco-Antona
Journal:  Int J Mol Sci       Date:  2022-06-11       Impact factor: 6.208

5.  A Case Series on Natural Conceptions Resulting in Ongoing Pregnancies in Menopausal and Prematurely Menopausal Women Following Platelet-Rich Plasma Treatment.

Authors:  Konstantinos Pantos; Mara Simopoulou; Agni Pantou; Anna Rapani; Petroula Tsioulou; Nikolaos Nitsos; Stephen Syrkos; Athanasios Pappas; Michael Koutsilieris; Konstantinos Sfakianoudis
Journal:  Cell Transplant       Date:  2019-07-04       Impact factor: 4.064

6.  Developmental Competence of Domestic Cat Vitrified Oocytes in 3D Enriched Culture Conditions.

Authors:  Martina Colombo; Maria Giorgia Morselli; Mariana Riboli Tavares; Maricy Apparicio; Gaia Cecilia Luvoni
Journal:  Animals (Basel)       Date:  2019-06-07       Impact factor: 2.752

Review 7.  Potential roles of experimental reproductive technologies in infertile women with diminished ovarian reserve.

Authors:  Zexu Jiao; Orhan Bukulmez
Journal:  J Assist Reprod Genet       Date:  2021-06-07       Impact factor: 3.357

8.  Normalized Ploidy Following 20 Consecutive Blastocysts with Chromosomal Error: Healthy 46, XY Pregnancy with IVF after Intraovarian Injection of Autologous Enriched Platelet-derived Growth Factors.

Authors:  E Scott Sills; Natalie S Rickers; Channel S Svid; J M Rickers; Samuel H Wood
Journal:  Int J Mol Cell Med       Date:  2019-05-15

9.  Live Birth in Woman With Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report.

Authors:  Chao-Chin Hsu; Leonard Hsu; Isabel Hsu; Yi-Jen Chiu; Sonam Dorjee
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-19       Impact factor: 5.555

10.  Live Birth Rates in Poor Responders' Group after Previous Treatment with Autologous Platelet-Rich Plasma and Low Dose Ovarian Stimulation Compared with Poor Responders Used Only Low Dose Ovarian Stimulation Before in Vitro Fertilization.

Authors:  Snezhana Stojkovska; Gligor Dimitrov; Nikoleta Stamenkovska; Makuli Hadzi-Lega; Zoran Petanovski
Journal:  Open Access Maced J Med Sci       Date:  2019-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.